Lotepred T Eye Drop

Lotepred T Eye Drop

Lotepred T Eye Drop is a high-potency ophthalmic intervention containing a synergistic blend of Loteprednol Etabonate (0.5% w/v) and Tobramycin (0.3% w/v), specifically engineered for the clinical management of steroid-responsive inflammatory ocular conditions where a risk of superficial bacterial infection exists. Utilizing a unique “Site-Specific Steroid” delivery system, this formulation works by inducing the synthesis of lipocortins to inhibit the inflammatory cascade, while concurrently delivering broad-spectrum aminoglycoside activity against susceptible pathogenic microorganisms. By modulating the release of arachidonic acid and inhibiting bacterial protein synthesis, Lotepred T effectively neutralizes the triggers of ocular edema, erythema, and microbial colonization. This targeted biochemical action provides a decisive therapeutic response by reinforcing the ocular surface defense and minimizing the potential for intraocular pressure (IOP) elevation typically associated with traditional corticosteroids.

Key Features

• Specifically formulated with Loteprednol to provide potent inflammation control with a significantly reduced risk of inducing glaucoma or cataracts.
• Clinically recognized for the role of Tobramycin in providing decisive coverage against Gram-positive and Gram-negative ocular pathogens.
• Specifically engineered to address both the inflammatory response and the microbial risk in a single ophthalmic delivery.
• Acts as a functional catalyst to reduce localized swelling and conjunctival congestion.
• Formulated as a sterile suspension to ensure sustained contact time and effective penetration into the ocular tissues.

Key Ingredients

• Loteprednol Etabonate (0.5% w/v)
• Tobramycin (0.3% w/v)
• Benzalkonium Chloride
• Povidone & Tyloxapol
• Edetate Disodium

Precautions

• Consult with an ophthalmologist prior to use, especially if you have a history of glaucoma, herpes simplex keratitis, or fungal ocular diseases.
• Prolonged use (exceeding 10 days) requires regular monitoring of intraocular pressure by an eye care professional.
• Remove contact lenses before instillation. Wait at least 15 minutes before reinserting lenses to prevent preservative-related ocular irritation.
• Do not touch the dropper tip to any surface, including the eye or eyelashes, as this can introduce exogenous pathogens into the sterile suspension.
• Prolonged use of antibiotics may result in the overgrowth of non-susceptible organisms, including fungi; discontinue if secondary infection is suspected.
• Keep the bottle tightly closed and store in an upright position in a cool, dry place (below 25°C); do not freeze.

How to Use

• Wash hands thoroughly. Shake the bottle well before each use to ensure the active ingredients are uniformly suspended.
• Instill 1 to 2 drops of Lotepred T into the conjunctival sac of the affected eye(s) every 4 to 6 hours.
• Tilt the head back, pull down the lower eyelid, and squeeze the bottle gently. Apply light pressure to the tear duct (nasolacrimal occlusion) for 1-2 minutes to minimize systemic absorption.
• During the initial 24 to 48 hours, the dosage may be increased to every 1 to 2 hours as directed by a specialist to manage acute inflammation.
• Do not discontinue use abruptly. Follow the physician’s instructions to gradually reduce the frequency of application to prevent inflammatory rebound.
• If using other eye drops, wait at least 5 to 10 minutes between the application of different products to prevent dilution.

Legal Disclaimer: Lotepred T Eye Drop is a prescription-only medication. Individual results vary based on the underlying ocular condition and the patient’s clinical response. This product is not intended for the treatment of viral or fungal infections of the eye. This information is for educational purposes and is not a substitute for professional medical consultation or a formal ophthalmic assessment.